198 related articles for article (PubMed ID: 30914272)
1. Backgrounded Membrane Imaging (BMI) for High-Throughput Characterization of Subvisible Particles During Biopharmaceutical Drug Product Development.
Helbig C; Ammann G; Menzen T; Friess W; Wuchner K; Hawe A
J Pharm Sci; 2020 Jan; 109(1):264-276. PubMed ID: 30914272
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Subvisible Particles in Biotherapeutic Prefilled Syringes: The Role of Polysorbate and Protein on the Formation of Silicone Oil and Protein Subvisible Particles After Drop Shock.
Jiao N; Barnett GV; Christian TR; Narhi LO; Joh NH; Joubert MK; Cao S
J Pharm Sci; 2020 Jan; 109(1):640-645. PubMed ID: 31689431
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of aggregate and silicone-oil counts in pre-filled siliconized syringes: An orthogonal study characterising the entire subvisible size range.
Shah M; Rattray Z; Day K; Uddin S; Curtis R; van der Walle CF; Pluen A
Int J Pharm; 2017 Mar; 519(1-2):58-66. PubMed ID: 28089934
[TBL] [Abstract][Full Text] [Related]
4. Quantification and characterization of micrometer and submicrometer subvisible particles in protein therapeutics by use of a suspended microchannel resonator.
Patel AR; Lau D; Liu J
Anal Chem; 2012 Aug; 84(15):6833-40. PubMed ID: 22794526
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Incremental Siliconization Levels on Soluble Aggregates, Submicron and Subvisible Particles in a Prefilled Syringe Product.
Bai S; Landsman P; Spencer A; DeCollibus D; Vega F; Temel DB; Houde D; Henderson O; Brader ML
J Pharm Sci; 2016 Jan; 105(1):50-63. PubMed ID: 26852839
[TBL] [Abstract][Full Text] [Related]
6. Particle Characterization for a Protein Drug Product Stored in Pre-Filled Syringes Using Micro-Flow Imaging, Archimedes, and Quartz Crystal Microbalance with Dissipation.
Zheng S; Puri A; Li J; Jaiswal A; Adams M
AAPS J; 2017 Jan; 19(1):110-116. PubMed ID: 27620008
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometry: a promising technique for the study of silicone oil-induced particulate formation in protein formulations.
Ludwig DB; Trotter JT; Gabrielson JP; Carpenter JF; Randolph TW
Anal Biochem; 2011 Mar; 410(2):191-9. PubMed ID: 21146492
[TBL] [Abstract][Full Text] [Related]
8. Cross-linked silicone coating: a novel prefilled syringe technology that reduces subvisible particles and maintains compatibility with biologics.
Depaz RA; Chevolleau T; Jouffray S; Narwal R; Dimitrova MN
J Pharm Sci; 2014 May; 103(5):1384-93. PubMed ID: 24643773
[TBL] [Abstract][Full Text] [Related]
9. Oil-Immersion Flow Imaging Microscopy for Quantification and Morphological Characterization of Submicron Particles in Biopharmaceuticals.
Krause N; Kuhn S; Frotscher E; Nikels F; Hawe A; Garidel P; Menzen T
AAPS J; 2021 Jan; 23(1):13. PubMed ID: 33398482
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the effect of syringe surfaces on protein formulations.
Majumdar S; Ford BM; Mar KD; Sullivan VJ; Ulrich RG; D'souza AJ
J Pharm Sci; 2011 Jul; 100(7):2563-73. PubMed ID: 21319164
[TBL] [Abstract][Full Text] [Related]
11. Qualitative High-Throughput Analysis of Subvisible Particles in Biological Formulations Using Backgrounded Membrane Imaging.
Murphy MI; Bruque M; Hanford A; Trayton I; Handali M; Leissa JA; Hasige S; Day K; Patel SM
J Pharm Sci; 2022 Jun; 111(6):1605-1613. PubMed ID: 35318031
[TBL] [Abstract][Full Text] [Related]
12. Imaging Flow Cytometry for Sizing and Counting of Subvisible Particles in Biotherapeutics.
Helbig C; Menzen T; Wuchner K; Hawe A
J Pharm Sci; 2022 Sep; 111(9):2458-2470. PubMed ID: 35777484
[TBL] [Abstract][Full Text] [Related]
13. Effect of the siliconization method on particle generation in a monoclonal antibody formulation in pre-filled syringes.
Gerhardt A; Nguyen BH; Lewus R; Carpenter JF; Randolph TW
J Pharm Sci; 2015 May; 104(5):1601-9. PubMed ID: 25740412
[TBL] [Abstract][Full Text] [Related]
14. Improving Diameter Accuracy for Dynamic Imaging Microscopy for Different Particle Types.
Cavicchi RE; Ripple DC;
J Pharm Sci; 2020 Jan; 109(1):488-495. PubMed ID: 31628920
[TBL] [Abstract][Full Text] [Related]
15. Albinterferon α2b adsorption to silicone oil-water interfaces: effects on protein conformation, aggregation, and subvisible particle formation.
Basu P; Blake-Haskins AW; O'Berry KB; Randolph TW; Carpenter JF
J Pharm Sci; 2014 Feb; 103(2):427-36. PubMed ID: 24382812
[TBL] [Abstract][Full Text] [Related]
16. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress.
Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF
PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805
[TBL] [Abstract][Full Text] [Related]
17. Shape Characterization of Subvisible Particles Using Dynamic Imaging Analysis.
Mathaes R; Manning MC; Winter G; Engert J; Wilson GA
J Pharm Sci; 2020 Jan; 109(1):375-379. PubMed ID: 31476311
[TBL] [Abstract][Full Text] [Related]
18. Identification of Subvisible Particles in Biopharmaceutical Formulations Using Raman Spectroscopy Provides Insight into Polysorbate 20 Degradation Pathway.
Saggu M; Liu J; Patel A
Pharm Res; 2015 Sep; 32(9):2877-88. PubMed ID: 25773722
[TBL] [Abstract][Full Text] [Related]
19. Friability Testing as a New Stress-Stability Assay for Biopharmaceuticals.
Torisu T; Maruno T; Yoneda S; Hamaji Y; Honda S; Ohkubo T; Uchiyama S
J Pharm Sci; 2017 Oct; 106(10):2966-2978. PubMed ID: 28603019
[TBL] [Abstract][Full Text] [Related]
20. Impact of Drug Formulation Variables on Silicone Oil Structure and Functionality of Prefilled Syringe System.
Shi GH; Gopalrathnam G; Shinkle SL; Dong X; Hofer JD; Jensen EC; Rajagopalan N
PDA J Pharm Sci Technol; 2018; 72(1):50-61. PubMed ID: 29030531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
